283 related articles for article (PubMed ID: 11741396)
1. Activation of caspase-8 in the Alzheimer's disease brain.
Rohn TT; Head E; Nesse WH; Cotman CW; Cribbs DH
Neurobiol Dis; 2001 Dec; 8(6):1006-16. PubMed ID: 11741396
[TBL] [Abstract][Full Text] [Related]
2. Caspase-9 activation and caspase cleavage of tau in the Alzheimer's disease brain.
Rohn TT; Rissman RA; Davis MC; Kim YE; Cotman CW; Head E
Neurobiol Dis; 2002 Nov; 11(2):341-54. PubMed ID: 12505426
[TBL] [Abstract][Full Text] [Related]
3. Correlation between caspase activation and neurofibrillary tangle formation in Alzheimer's disease.
Rohn TT; Head E; Su JH; Anderson AJ; Bahr BA; Cotman CW; Cribbs DH
Am J Pathol; 2001 Jan; 158(1):189-98. PubMed ID: 11141492
[TBL] [Abstract][Full Text] [Related]
4. nNOS expressing neurons in the entorhinal cortex and hippocampus are affected in patients with Alzheimer's disease.
Thorns V; Hansen L; Masliah E
Exp Neurol; 1998 Mar; 150(1):14-20. PubMed ID: 9514829
[TBL] [Abstract][Full Text] [Related]
5. Caspase activation in the limbic cortex of subjects with early Alzheimer's disease.
Gastard MC; Troncoso JC; Koliatsos VE
Ann Neurol; 2003 Sep; 54(3):393-8. PubMed ID: 12953274
[TBL] [Abstract][Full Text] [Related]
6. Caspase-3-mediated cleavage of PHF-1 tau during apoptosis irrespective of excitotoxicity and oxidative stress: an implication to Alzheimer's disease.
Kang HJ; Yoon WJ; Moon GJ; Kim DY; Sohn S; Kwon HJ; Gwag BJ
Neurobiol Dis; 2005 Apr; 18(3):450-8. PubMed ID: 15755671
[TBL] [Abstract][Full Text] [Related]
7. No difference in expression of apoptosis-related proteins and apoptotic morphology in control, pathologically aged and Alzheimer's disease cases.
Woodhouse A; Dickson TC; West AK; McLean CA; Vickers JC
Neurobiol Dis; 2006 May; 22(2):323-33. PubMed ID: 16406795
[TBL] [Abstract][Full Text] [Related]
8. Activation of caspase-6 in aging and mild cognitive impairment.
Albrecht S; Bourdeau M; Bennett D; Mufson EJ; Bhattacharjee M; LeBlanc AC
Am J Pathol; 2007 Apr; 170(4):1200-9. PubMed ID: 17392160
[TBL] [Abstract][Full Text] [Related]
9. Accumulation of caspase cleaved amyloid precursor protein represents an early neurodegenerative event in aging and in Alzheimer's disease.
Zhao M; Su J; Head E; Cotman CW
Neurobiol Dis; 2003 Dec; 14(3):391-403. PubMed ID: 14678756
[TBL] [Abstract][Full Text] [Related]
10. Oxidative stress in Alzheimer's disease hippocampus: a topographical study.
Cruz-Sánchez FF; Gironès X; Ortega A; Alameda F; Lafuente JV
J Neurol Sci; 2010 Dec; 299(1-2):163-7. PubMed ID: 20863531
[TBL] [Abstract][Full Text] [Related]
11. nNOS expression in reactive astrocytes correlates with increased cell death related DNA damage in the hippocampus and entorhinal cortex in Alzheimer's disease.
Simic G; Lucassen PJ; Krsnik Z; Kruslin B; Kostovic I; Winblad B; Bogdanovi
Exp Neurol; 2000 Sep; 165(1):12-26. PubMed ID: 10964481
[TBL] [Abstract][Full Text] [Related]
12. Caspase-cleaved amyloid precursor protein and activated caspase-3 are co-localized in the granules of granulovacuolar degeneration in Alzheimer's disease and Down's syndrome brain.
Su JH; Kesslak JP; Head E; Cotman CW
Acta Neuropathol; 2002 Jul; 104(1):1-6. PubMed ID: 12070657
[TBL] [Abstract][Full Text] [Related]
13. Beta-amyloid deposition and neurofibrillary tangle association with caspase activation in Down syndrome.
Head E; Lott IT; Cribbs DH; Cotman CW; Rohn TT
Neurosci Lett; 2002 Sep; 330(1):99-103. PubMed ID: 12213643
[TBL] [Abstract][Full Text] [Related]
14. Sequestration of RNA in Alzheimer's disease neurofibrillary tangles and senile plaques.
Ginsberg SD; Crino PB; Lee VM; Eberwine JH; Trojanowski JQ
Ann Neurol; 1997 Feb; 41(2):200-9. PubMed ID: 9029069
[TBL] [Abstract][Full Text] [Related]
15. Sublethal concentrations of prion peptide PrP106-126 or the amyloid beta peptide of Alzheimer's disease activates expression of proapoptotic markers in primary cortical neurons.
White AR; Guirguis R; Brazier MW; Jobling MF; Hill AF; Beyreuther K; Barrow CJ; Masters CL; Collins SJ; Cappai R
Neurobiol Dis; 2001 Apr; 8(2):299-316. PubMed ID: 11300725
[TBL] [Abstract][Full Text] [Related]
16. Apoptotic signals within the basal forebrain cholinergic neurons in Alzheimer's disease.
Wu CK; Thal L; Pizzo D; Hansen L; Masliah E; Geula C
Exp Neurol; 2005 Oct; 195(2):484-96. PubMed ID: 16085017
[TBL] [Abstract][Full Text] [Related]
17. Expression profile of transcripts in Alzheimer's disease tangle-bearing CA1 neurons.
Ginsberg SD; Hemby SE; Lee VM; Eberwine JH; Trojanowski JQ
Ann Neurol; 2000 Jul; 48(1):77-87. PubMed ID: 10894219
[TBL] [Abstract][Full Text] [Related]
18. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.
van de Nes JA; Nafe R; Schlote W
Brain Res; 2008 Jun; 1213():152-65. PubMed ID: 18455153
[TBL] [Abstract][Full Text] [Related]
19. Transneuronally altered dendritic processing of tangle-free neurons in Alzheimer's disease.
Ohm TG; Münch S; Schönheit B; Zarski R; Nitsch R
Acta Neuropathol; 2002 May; 103(5):437-43. PubMed ID: 11935258
[TBL] [Abstract][Full Text] [Related]
20. Activated caspase-3 expression in Alzheimer's and aged control brain: correlation with Alzheimer pathology.
Su JH; Zhao M; Anderson AJ; Srinivasan A; Cotman CW
Brain Res; 2001 Apr; 898(2):350-7. PubMed ID: 11306022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
